EMBL-EBI Announcements

Ontology Mapping Service logo

18 Dec 2017

Ontology Mapping Service: an EMBL-EBI – industry collaboration

Scientists working in many sectors, disciplines, countries and languages use different types of data about drugs and diseases for their research. Discoverability is a perpetual challenge.

Open Targets background and logo

04 Dec 2017

Takeda joins drug target discovery initiative

Open Targets announced today that Takeda has joined its pioneering public-private collaboration to transform drug discovery by improving the success rate for developing new medicines. Takeda is a global, R&D-driven pharmaceutical company with expertise in oncology, gastroenterology (GI) and central nervous system (CNS) disease that will complement the offerings of GSK, Biogen, the Wellcome Trust Sanger Institute and the European Bioinformatics Institute (EMBL-EBI), and build on the initiative’s success.